Unlocking the power of translational medicine Unlocking the power of translational medicine, Published online: 18 February 2019; doi:10.1038/d41573-019-00030-xUnlocking the power of translational...
The health safety requirement involves rigorous monitoring of the use of health products in real life. It is a legitimate and growing concern for health authorities and public authorities.
Proper use, product safety, risk assessment and practice quality, consumption data analysis provides a clear and precious picture for tracking, understanding, communicating and steering.
Thanks to the analysis of anonymised patient data, the OpenHealth longitudinal study produces indicators for the proper use of health products (analysis of profiles of treated patients, treatment methods, pharmaco-epidemiology, risk management plan...which up to now were complex and expensive to obtain.
Real time medicine sales data, combined with modelling resources, also enables indicators to be produced for epidemiological monitoring, for steering and real-time assessment of public action (vaccination campaigns, anticipation of the spread of flu etc.).
The first full web analytic tools for real-time health product tracking.Find out more